Exam 4 endocrine + Psych Flashcards
Neurotransmitters in major depressive disorder
Serotonin, NE, dopamine
Treatment phases of depression
Acute: 6-12 weeks
Continuation: 9 months-1 year
SSRI
Fluoxetine, citalopram, sertraline, fluvoxamine, paroxetine, escitalopram
Effective after 4-6 weeks
May decrease REM sleep
SE: Sexual dysfunction
Abrupt withdrawal causes flu like symptoms, insomnia, GI effects, anxiety
Only SSRI approved for children
Fluoxetine (Prozac)
SNRIs
Venlafaxine, desvenlafaxine, duloxetine, levomilnacipran
For more resistant depression
Takes 4-6 weeks
Higher rates of anticholinergic effects
TCAs
-triptyline and -amine
Worse SE than SSRI
Active at ACh and H receptors–anticholinergic effects
MAOI
Phenlzine
Decrease degradation of nE, serotonin, and dopamine
Potential for life threatening hypertension
Last line treatment
Neurotransmitters involved in anxiety disorders
NE, serotonin, GABA
Antidepressants for anxierty
SSRI or SNRI or imipramine (TCA)
1st line tx of anxiety
Benzodiazepines
Alprazolam (Xanax), clonazepam, diazepam, lorazepam (Ativan), oxazepam
bind to GABA A
Indicated for short term management (2-4 weeks) as well as exacerbations
Long term tx not recommended
SE: drowsiness and psychomotor impairment
Flumazenil for OD
Azapirones
Buspirone
Partial agonist at 5-HT1a receptor and inhibits uptake of dopamine, serotonin and NE
Used as adjunct therapy
No hypnotic, muscle relaxant or anticonvulsant properties
Not useful for immediate relief
Minimal abuse potential
Benzodiazepines for insomnia
Blocks thalamic, hypothalamic and limbic arousal
Tempazepam + Lorazpem–intermediate acting for sleep maintenance
Flurazepam–long acting and rapid onset for sleep initiation
Benzodiazepine receptor agonists
Eszoplicone, zolpidem (ambien), zaleplon
Induces sleepiness but not anxiolysis or muscle relaxation
Can increase sleep walking, eating and driving
Suvorexant
Blockage of orexin neuropeptides and results in severe sleepiness
Sleep induction and maintenance achieved
Ramelteon
Melatonin receptor agonists
Shortens latency to sleep onset
1st line therapy for insomnia
Benzo, benzo agonist, ramelteon
Ropinirole or pramipexole
Dopaminergic agent for restless leg syndrome
Quicker onset than dopamine agonists–useful for relief of sleep onset insomnia
Anticonvulsants for restless leg
Off label use
Considered when dopamine agonists have failed
Narcolepsy triad
Excessive daytime sleepiness, cataplexy, sleep related hallucinations, sleep paralysis
Modafenil and Armodafinil
Psychostimulant
Increase release of NE in hippocampus, thalamus and amygdala
Tx of narcolepsy
Methylphenidate
amphetemaines
tx of narcolepsy
Stimulants CNS activity and blocks reuptake of NE
Mirtazapine
Similar to TCA
Causes sedation
Alpha 2 antagonist/mixed serotonin blockers
Increases appetite and decreases insomnia